Table 1.
Potential Value for Serologic Testing | |
Assessing potential sequelae of prior infection | Delayed onset cytokine release syndrome |
… | PASC (“long COVID”) |
MIS-C, MIS-A | |
Qualifying convalescent plasma | |
Serologic Testing Not Indicated | |
Assessing need for COVID-19 vaccination | |
Testing of T-cell responses | |
Indications Where Data Are Evolving | |
Determining organ transplant candidacy | |
Prioritizing limited monoclonal antibody to patients most likely to benefit] |
Abbreviations: COVID, coronavirus disease 2019; MIS-A, multisystem inflammatory syndrome in adults; MIS-C, MIS in children; PASC, postacute sequelae of severe acute respiratory syndrome coronavirus 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.